Quick Answer
Longevity Health Holdings, Inc. reported Diluted EPS of $4.83 per share (loss) for fiscal year 2025.
Longevity Health Holdings, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$4.83 | +66.8% |
| 2024 | -$14.56 | -897.3% |
| 2023 | -$1.46 | +73.3% |
| 2022 | -$5.47 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.83 | +79.9% | +46.8% |
| June 30, 2025 | -$1.56 | +67.4% | -2.6% |
| March 31, 2025 | -$1.52 | +64.5% | +63.2% |
| September 30, 2024 | -$4.13 | -566.1% | +13.6% |
| June 30, 2024 | -$4.78 | +4.4% | -11.7% |
| March 31, 2024 | -$4.28 | -124.1% | -590.3% |
| September 30, 2023 | -$0.62 | +90.8% | +87.6% |
| June 30, 2023 | -$5.00 | — | -161.8% |
- Longevity Health Holdings, Inc. showed an increase of +66.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Longevity Health Holdings, Inc.’s diluted eps has grown by 11.7% (from $5.47 per share (loss) to $4.83 per share (loss)).
- The most recent figure is from Longevity Health Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: